arrow
T

Tobias Herold

helmholtz munich german research center for environmental health
H指数:47
被引数:9,350

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist

一种涵盖无细胞系的亚组、可连续移植的急性髓系白血病PDX模型平台

2026-10-050
OAAI
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study

吉列替尼与异基因造血干细胞移植序贯治疗复发/难治FMS样酪氨酸激酶3(FLT3)突变急性髓系白血病患者的多中心真实世界研究

2026-09-050
OAAI
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

4978例接受强化治疗的AML欧洲患者队列中,髓系发育异常相关基因突变的不同预后影响

Leukemia
IF13.4
2025-10-270
OA
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

跨大陆成人急性髓系白血病的多维分析揭示了突变景观和治疗结局中的年龄相关趋势(Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia
IF13.4
2025-09-190
OAAI
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma

全面的基因组学和转录组学分析能够实现针对腹膜和胸膜间皮瘤的分子引导治疗方案。

2025-04-010
OAAI
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation

移植前微小残留病(MRD)似乎不影响接受allo-HSCT的NPM1突变型急性髓系白血病患者的生存。

2025-02-040
OA
Improving risk stratification for 2022 European LeukemiaNet favorable- risk patients with acute myeloid leukemia
2024-11-010
OAAI
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse
LEUKEMIA
IF13.4
2024-08-221
OAAI
Friday Leukemia-a Structural Phenomenon
2024-02-090
OA
Prognostic impact of CEBPA mutational subgroups in adult AML
LEUKEMIA
IF13.4
2024-01-165
OAAI
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)
LEUKEMIA
IF13.4
2023-11-289
OAAI
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

2023-09-2911
OAAI
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European leukemia net risk classification
LEUKEMIA
IF13.4
2023-09-0711
OAAI
Combined proteomics and CRISPR-Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo
2023-07-088
OAAI